537 related articles for article (PubMed ID: 16157589)
21. Lysine 63-linked polyubiquitination of TAK1 at lysine 158 is required for tumor necrosis factor alpha- and interleukin-1beta-induced IKK/NF-kappaB and JNK/AP-1 activation.
Fan Y; Yu Y; Shi Y; Sun W; Xie M; Ge N; Mao R; Chang A; Xu G; Schneider MD; Zhang H; Fu S; Qin J; Yang J
J Biol Chem; 2010 Feb; 285(8):5347-60. PubMed ID: 20038579
[TBL] [Abstract][Full Text] [Related]
22. NF-kappaB and activator protein 1 response elements and the role of histone modifications in IL-1beta-induced TGF-beta1 gene transcription.
Lee KY; Ito K; Hayashi R; Jazrawi EP; Barnes PJ; Adcock IM
J Immunol; 2006 Jan; 176(1):603-15. PubMed ID: 16365456
[TBL] [Abstract][Full Text] [Related]
23. Minocycline targets the NF-κB Nexus through suppression of TGF-β1-TAK1-IκB signaling in ovarian cancer.
Ataie-Kachoie P; Badar S; Morris DL; Pourgholami MH
Mol Cancer Res; 2013 Oct; 11(10):1279-91. PubMed ID: 23858099
[TBL] [Abstract][Full Text] [Related]
24. A small peptide modeled after the NRAGE repeat domain inhibits XIAP-TAB1-TAK1 signaling for NF-κB activation and apoptosis in P19 cells.
Rochira JA; Matluk NN; Adams TL; Karaczyn AA; Oxburgh L; Hess ST; Verdi JM
PLoS One; 2011; 6(7):e20659. PubMed ID: 21789165
[TBL] [Abstract][Full Text] [Related]
25. cIAP1, cIAP2, and XIAP act cooperatively via nonredundant pathways to regulate genotoxic stress-induced nuclear factor-kappaB activation.
Jin HS; Lee DH; Kim DH; Chung JH; Lee SJ; Lee TH
Cancer Res; 2009 Mar; 69(5):1782-91. PubMed ID: 19223549
[TBL] [Abstract][Full Text] [Related]
26. TAK1-dependent activation of AP-1 and c-Jun N-terminal kinase by receptor activator of NF-kappaB.
Lee SW; Han SI; Kim HH; Lee ZH
J Biochem Mol Biol; 2002 Jul; 35(4):371-6. PubMed ID: 12296995
[TBL] [Abstract][Full Text] [Related]
27. Activation of the hematopoietic progenitor kinase-1 (HPK1)-dependent, stress-activated c-Jun N-terminal kinase (JNK) pathway by transforming growth factor beta (TGF-beta)-activated kinase (TAK1), a kinase mediator of TGF beta signal transduction.
Wang W; Zhou G; Hu MC; Yao Z; Tan TH
J Biol Chem; 1997 Sep; 272(36):22771-5. PubMed ID: 9278437
[TBL] [Abstract][Full Text] [Related]
28. IAP suppression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspase inhibition.
Sanna MG; da Silva Correia J; Ducrey O; Lee J; Nomoto K; Schrantz N; Deveraux QL; Ulevitch RJ
Mol Cell Biol; 2002 Mar; 22(6):1754-66. PubMed ID: 11865055
[TBL] [Abstract][Full Text] [Related]
29. TAK1 lysine 158 is required for TGF-β-induced TRAF6-mediated Smad-independent IKK/NF-κB and JNK/AP-1 activation.
Mao R; Fan Y; Mou Y; Zhang H; Fu S; Yang J
Cell Signal; 2011 Jan; 23(1):222-7. PubMed ID: 20837137
[TBL] [Abstract][Full Text] [Related]
30. Smad6 inhibits non-canonical TGF-β1 signalling by recruiting the deubiquitinase A20 to TRAF6.
Jung SM; Lee JH; Park J; Oh YS; Lee SK; Park JS; Lee YS; Kim JH; Lee JY; Bae YS; Koo SH; Kim SJ; Park SH
Nat Commun; 2013; 4():2562. PubMed ID: 24096742
[TBL] [Abstract][Full Text] [Related]
31. Xenopus death-domain-containing proteins FADD and RIP1 synergistically activate JNK and NF-kappaB.
Ishizawa YH; Tamura K; Yamaguchi T; Matsumoto K; Komiyama M; Takamatsu N; Shiba T; Ito M
Biol Cell; 2006 Aug; 98(8):465-78. PubMed ID: 16597320
[TBL] [Abstract][Full Text] [Related]
32. Potentiation of Smad transactivation by Jun proteins during a combined treatment with epidermal growth factor and transforming growth factor-beta in rat hepatocytes. role of phosphatidylinositol 3-kinase-induced AP-1 activation.
Peron P; Rahmani M; Zagar Y; Durand-Schneider AM; Lardeux B; Bernuau D
J Biol Chem; 2001 Mar; 276(13):10524-31. PubMed ID: 11134003
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor-β1 induces matrix metalloproteinase-9 and cell migration in astrocytes: roles of ROS-dependent ERK- and JNK-NF-κB pathways.
Hsieh HL; Wang HH; Wu WB; Chu PJ; Yang CM
J Neuroinflammation; 2010 Dec; 7():88. PubMed ID: 21134288
[TBL] [Abstract][Full Text] [Related]
34. Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation.
Sung B; Pandey MK; Aggarwal BB
Mol Pharmacol; 2007 Jun; 71(6):1703-14. PubMed ID: 17387141
[TBL] [Abstract][Full Text] [Related]
35. Liver protection from apoptosis requires both blockage of initiator caspase activities and inhibition of ASK1/JNK pathway via glutathione S-transferase regulation.
Gilot D; Loyer P; Corlu A; Glaise D; Lagadic-Gossmann D; Atfi A; Morel F; Ichijo H; Guguen-Guillouzo C
J Biol Chem; 2002 Dec; 277(51):49220-9. PubMed ID: 12370186
[TBL] [Abstract][Full Text] [Related]
36. Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-kappaB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activation.
Dai Y; Rahmani M; Dent P; Grant S
Mol Cell Biol; 2005 Jul; 25(13):5429-44. PubMed ID: 15964800
[TBL] [Abstract][Full Text] [Related]
37. ILPIP, a novel anti-apoptotic protein that enhances XIAP-mediated activation of JNK1 and protection against apoptosis.
Sanna MG; da Silva Correia J; Luo Y; Chuang B; Paulson LM; Nguyen B; Deveraux QL; Ulevitch RJ
J Biol Chem; 2002 Aug; 277(34):30454-62. PubMed ID: 12048196
[TBL] [Abstract][Full Text] [Related]
38. Requirement of TGF-beta receptor-dependent activation of c-Jun N-terminal kinases (JNKs)/stress-activated protein kinases (Sapks) for TGF-beta up-regulation of the urokinase-type plasminogen activator receptor.
Yue J; Sun B; Liu G; Mulder KM
J Cell Physiol; 2004 May; 199(2):284-92. PubMed ID: 15040011
[TBL] [Abstract][Full Text] [Related]
39. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
[TBL] [Abstract][Full Text] [Related]
40. Transforming growth factor-beta inhibition of insulin-like growth factor-binding protein-5 synthesis in skeletal muscle cells involves a c-Jun N-terminal kinase-dependent pathway.
Rousse S; Lallemand F; Montarras D; Pinset C; Mazars A; Prunier C; Atfi A; Dubois C
J Biol Chem; 2001 Dec; 276(50):46961-7. PubMed ID: 11598109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
